Cases of MS in individuals who are receiving immunosuppressive/immunomodulatory treatment also deserve attention, with a few cases of MS associated with anti-tumor necrosis factor (TNF), adalimumab, or infliximab reported in the literature. This evidence concerns the gene TNF and myeloid sarcoma.